期刊
JOURNAL OF IMMUNOLOGY
卷 164, 期 9, 页码 4819-4825出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.164.9.4819
关键词
-
类别
资金
- NIAID NIH HHS [AI26918] Funding Source: Medline
contrast to intact BALB/c mice, BALB/c mice rendered deficient in V beta 4(+) CD4(+) T cells develop a Th1 response to infection with Leishmania major and are resistant. V beta 4-deficient BALB/c mice are unable to generate the early IL-4 transcription occurring in V beta 4 V alpha 8 CD4(+) T cells of BALB/c mice within 1 day of infection. Here we demonstrate that treatment of V beta 4-deficient BALB/c mice with IL-4 during the first 64 h after infection instructs Th2 cell development and susceptibility to infection. The demonstrated inability of IL-4 to reverse the resistant phenotype of BALB/c mice treated with anti-CD4 mAb the day before infection suggest that these effects of IL-4 require its interaction,vith CD4(+) T cells. In contrast to draining lymph node cells from BALB/c mice, cells from V beta 4-deficient BALB/c mice remain responsive to IL-12 following infection. Strikingly, administration of IL-4 to V beta 4-deficient BALB/c mice renders their lymph node cells unresponsive to IL-12 by down-regulating IL-12R beta 2-chain expression. This study directly demonstrates that in BALB/c mice IL-4 is necessary and sufficient to initiate the molecular events steering Th2 cell maturation and susceptibility to L. major.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据